MedTrace Logo

Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Cartilage

NCT01836757 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-04-22

No results posted yet for this study

Summary

To delineate the effect of MSM on osteoarthritis

Conditions

Interventions

DRUG

MethylSulfonylMethane (MSM)

Intervention is MSM 3 gr twice a day for 26 weeks (6 gr/day total)

DRUG

Placebo

Sponsors & Collaborators

  • G.Papanikolaou Research Group

    lead OTHER

Principal Investigators

  • Thomas Pagonis, MD, PhD · Aristotle's University of Thessaloniki

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01836757 on ClinicalTrials.gov